Neumora Therapeutics, Inc. - Common Stock (NQ:NMRA)

0.5253 +0.0254 (+5.08%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neumora Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 15, 2024

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic...

Via Benzinga

Crude Oil Down 1%; Charles Schwab Sales Top Estimates ↗

April 15, 2024

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 38,114.61 while the NASDAQ rose 0.07% to 16,187.02. The S&P...

Via Benzinga

Topics Stocks

Analyst Expectations for Neumora Therapeutics's Future ↗

November 08, 2023

Via Benzinga

Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday? ↗

April 15, 2024

Neumora Therapeutics faces setbacks as FDA halts Phase 1 trial of NMRA-266 due to convulsion concerns in rabbits. Phase 1 study paused; company working with FDA for resolution.

Via Benzinga

Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug ↗

April 15, 2024

The company was testing a potential treatment for schizophrenia in rabbits, but found a notable side effect.

Via Investor's Business Daily

Why Is Mobile Global Esports (MGAM) Stock Down 18% Today? ↗

April 15, 2024

Mobile Global Esports stock is falling on Monday after the company revealed that shares of MGAM will be delisted later this week.

Via InvestorPlace

Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today? ↗

April 15, 2024

Neumora Therapeutics stock is falling on Monday as investors in NMRA shares react to a clinical trial being put on hold by the FDA.

Via InvestorPlace

Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 15, 2024

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Monday.

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 15, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 15, 2024

We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!

Via InvestorPlace

Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study

April 15, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 13, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday ↗

March 13, 2024

U.S. stocks were mixed, with the Dow Jones index surging more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days

March 13, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023 ↗

March 07, 2024

NMRA stock results show that Neumora Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

March 07, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officer

January 22, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 22, 2023

Via Benzinga

Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday ↗

December 22, 2023

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of Karuna Therapeutics, Inc. (NASDAQ: KRTX) rose sharply during Friday’s session following acquisition...

Via Benzinga

Topics Stocks

7 Stocks with Strong Insider Buying: December 2023 ↗

December 17, 2023

Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024.

Via InvestorPlace

Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer

December 12, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

December 04, 2023

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...

Via Benzinga

Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket ↗

November 30, 2023

Shares of Salesforce, Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 30, 2023

It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!

Via InvestorPlace

Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study

November 27, 2023

NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment of schizophrenia

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

November 01, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

Neumora Therapeutics to Participate in Upcoming Conferences in November

October 30, 2023

From Neumora Therapeutics, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.